IRONWOOD PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $454.2M | $605.9M | $620.1M |
| FY2022 | $396.3M | $652.4M | $656.2M |
| FY2023 | — | $-346.3M | $92.2M |
| FY2024 | — | $-301.3M | $88.6M |
| FY2025 | — | $-261.8M | $215.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $454.2M | $605.9M | $620.1M |
| FY2022 | $396.3M | $652.4M | $656.2M |
| FY2023 | — | $-346.3M | $92.2M |
| FY2024 | — | $-301.3M | $88.6M |
| FY2025 | — | $-261.8M | $215.5M |